Introduction
============

Status epilepticus (SE) is an emergency neurological condition defined as a continuous seizure of more than 5 minutes.[@b1-ndt-11-1097] Its prevalence varies between 10 and 41 cases per 100,000 population outside of Thailand.[@b2-ndt-11-1097] In Thailand, SE occurred in 5.10 cases per 100,000 population with a mortality rate of 0.6 per 100,000 population.[@b3-ndt-11-1097] Causes of SE are different between countries. A report from Taiwan showed that central nervous system infection and previous strokes are the two most common causes of SE,[@b4-ndt-11-1097] while antiepileptic drug (AED) withdrawal and alcohol-related causes were leading causes of SE in Western countries.[@b5-ndt-11-1097]

Factors associated with poor outcomes of SE were related to comorbid complications such as metabolic disorders, cerebrovascular disease, and hypoxemia as shown in systematic reviews.[@b6-ndt-11-1097],[@b7-ndt-11-1097] A report from Thailand did not find any significant predictors for SE.[@b2-ndt-11-1097] Unlike in Western countries, there are limited data on predictors of SE outcomes in Thailand and other Asian countries. Here, the study was aimed to determine whether any factors associated with initial laboratory findings or treatment of SE had influences on outcomes at discharge.

Materials and methods
=====================

This study retrospectively reviewed charts of adult patients who were at least 15 years old and diagnosed as SE at Khon Kaen Hospital from October 1, 2010 to September 30, 2012. SE patients were identified by using the International Classification of Diseases code G41. Khon Kaen Hospital is the tertiary care hospital located in the northeastern part of Thailand.

Baseline characteristics, initial laboratory findings, treatment, and treatment outcomes were recorded. Patients were categorized into two groups by type of discharge status and neurological outcomes; good or poor outcomes. Good outcomes were defined by improvement at discharge and absence of neurological deficits, while poor outcomes were defined by: not being improved at discharge; being discharged against advice; death; or presence of a neurological deficit.

Statistical analysis
====================

Descriptive statistics were used to detect significant differences between patients with good and poor outcomes. Univariate logistic regression analysis was applied to calculate the crude odds ratios (ORs) of individual variables for having poor outcomes. All variables with *P*\<0.20 in univariate analysis were included in subsequent multivariate logistic regression analysis. The final model was composed of factors associated with poor outcomes. Analytical results are presented as adjusted ORs, and 95% confidence intervals.

The study protocol was approved by an institutional review committee, Khon Kaen University (HE 561217).

Results
=======

During the study period, there were 211 patients diagnosed as SE. Of those, 130 patients were male (61.61%). The mean age (standard deviation \[SD\]) of all patients was 53.28 years (15.92). Epilepsy (24.64%) and hypertension (23.22%) were the two most common comorbid diseases. Generalized tonic--clonic seizure was the most common type of SE (179 patients; 94.71%). Acute stroke was the most common cause of SE in 33 patients (15.64%). Other common causes of SE are shown in [Table 1](#t1-ndt-11-1097){ref-type="table"}. The mean (SD) numbers of AEDs used were 2.05 (1.56) and the mean (SD) length of stay was 5.12 days (6.75). There were 104 patients (49.29%) who developed complications after SE and the most common complication was aspiration pneumonia (53 patients; 25.12%).

At discharge, there were 120 patients (56.87%) who had good outcomes, while 91 patients (43.13%) had poor outcomes categorized by: death (29 patients; 13.74%); not improved or discharged against advice (55 patients; 26.07%); and presence of neurological deficits (7 patients; 3.32%). Most clinical factors at initial presentation were comparable between those who had good and poor outcomes at discharge ([Tables 2](#t2-ndt-11-1097){ref-type="table"} and [3](#t3-ndt-11-1097){ref-type="table"}). Those who had poor outcomes had more SE occurrences in hospital (30.77% versus 3.33%), a lower Glasgow coma scale (7.97 versus 9.78), higher plasma glucose (203.11 versus 159.26 mg/dL), lower serum albumin (2.73 versus 3.52 g/dL), higher serum aspartate aminotransferase (171.36 versus 82.78 U/L), and higher total bilirubin (1.84 versus 1.04 mg/dL) than those with good outcomes. The serum electrolytes, except for potassium and phosphate levels, were also statistically different between those who had good and poor outcomes ([Table 3](#t3-ndt-11-1097){ref-type="table"}). In the final model of multivariate analysis, only plasma glucose was significantly associated with poor outcomes with an adjusted OR of 1.012 (95% confidence interval of 1.003 and 1.021).

Regarding treatment and treatment outcomes, those with poor outcomes had a higher proportion of recurrent SE (42.86% versus 10.83%) and longer duration of respirator use (4.18 versus 1.83 days) as shown in [Table 4](#t4-ndt-11-1097){ref-type="table"}.

Discussion
==========

This study showed two important findings: poor discharge status of SE in a tertiary care hospital was 43.13% and the discharge status of SE patients was associated with initial plasma glucose levels. An increase of 1 mg/dL of plasma glucose increased the risk of having poor discharge status by 1.2%.

A previous study from Singapore also showed that in SE patients with a hyperglycemia equal to or more than 7 mmol/L (126 mg/dL), these levels were associated with poor outcomes of SE.[@b8-ndt-11-1097] In animal models, hyperglycemia causes hippocampal damage and also aggravates seizures.[@b9-ndt-11-1097],[@b10-ndt-11-1097] Therefore, glucose control may be important in SE patients, particularly in Asian populations. These results may not apply to Western populations. Two studies from Switzerland did not have findings similar to this study.[@b11-ndt-11-1097],[@b12-ndt-11-1097] Hyperglycemia was, however, shown to be associated with poor outcome in acute ischemic stroke.[@b13-ndt-11-1097]

Some factors such as serum albumin or aspartate aminotransferase were significantly different between the good and poor SE outcomes by univariate logistic analysis or descriptive statistics. Both factors, however, were not statistically significant in the multivariate logistic regression analysis. These results implied that only plasma glucose was an independent factor or predictor for SE outcome.

The population of this study may be different from other previous studies in terms of causes of SE. In the current study, acute stroke, alcohol related causes, and septic encephalopathy accounted for 41.23% of the entire subjects. Unlike in Western populations, AED withdrawal was found only in 9%. The previous study from Thailand found that the mortality rate of SE was 35%,[@b2-ndt-11-1097] while refractory SE may have a mortality rate of 50%.[@b14-ndt-11-1097],[@b15-ndt-11-1097] The poor outcome rate of this study was 43.13%. The poor discharge statuses were one of the following: death; not improved or discharged against advice; or presence of a neurological deficit.

The strengths of this study were the quite-large sample size and different causes of SE as compared with previous studies.[@b11-ndt-11-1097],[@b12-ndt-11-1097] There are some limitations. Retrospective data collection may not have complete data, particularly laboratory findings such as HbA~1c~ levels or history of previous medications that may affect plasma glucose levels such as steroid use. Also noted was that the population in this study was mostly not refractory SE; only three and two patients had received midazolam and propofol, respectively. Further studies are needed particularly in refractory SE. The results of this study may apply only to Asian populations or other countries in Southeast Asia.

Conclusion
==========

Initial plasma glucose is associated with poor discharge status in patients with SE.

This study was supported by TRF grants from Senior Research Scholar Grant, Thailand Research Fund grant number RTA5580004 and the Higher Education Research Promotion and National Research University Project of Thailand, Office of the Higher Education Commission, Thailand through the Health Cluster (SHeP-GMS), Khon Kaen University. The authors also would like to thank Dr Thanachai Panaput for his kind advice on statistical analyses, Ms Kanokwan Boonpracheon (medical student) for her assistance in data management, and Professor James A Will (University of Wisconsin, Madison, WI, USA) for review of the manuscript.

**Disclosure**

The authors report no conflicts of interest in this work.

###### 

Causes of status epilepticus in the present study

  Causes                                  Number (%)
  --------------------------------------- ------------
  Acute stroke                            33 (15.64)
  Alcohol related (withdrawal/toxicity)   30 (14.22)
  Sepsis                                  24 (11.37)
  Central nervous system infection        19 (9.00)
  AED withdrawal                          19 (9.00)
  Cardiac arrest                          18 (8.53)
  Post-stroke                             11 (5.21)
  Subtherapeutic AED level                11 (5.21)
  Hyponatremia                            7 (3.32)
  Hyper-/hypoglycemia                     5 (2.37)
  Acute subdural hematoma                 4 (1.90)
  Uremia                                  4 (1.90)
  Acute febrile illness                   4 (1.90)
  Hypertensive encephalopathy             4 (1.90)
  Sleep deprivation                       4 (1.90)
  Venous sinus thrombosis                 3 (1.42)
  Others                                  11 (5.21)

**Notes:** "Others" were autoimmune encephalitis, brain abscess, hydrocephalus, central nervous system vasculitis, hypocalcemia, intracerebral hemorrhage, posterior reversible encephalopathy syndrome, subarachnoid hemorrhage, and subdural hygroma.

**Abbreviation:** AED, antiepileptic drug.

###### 

Clinical factors at initial presentation of patients with SE categorized by type of hospital discharge

  ---------------------------------------------------------------------------
  Factors                         Good outcome\   Poor outcome\   *P*-value
                                  N=120           N=91            
  ------------------------------- --------------- --------------- -----------
  Male                            76 (63.33)      54 (59.39)      0.555

  Mean age (SD), years            52.71 (18.71)   54.04 (19.58)   0.655

  Comorbid diseases                                               

   Hypertension                   28 (23.33)      21 (23.08)      0.965

   Diabetes mellitus              23 (19.17)      16 (17.58)      0.769

   Alcoholism                     13 (10.83)      7 (7.69)        0.445

   Stroke                         27 (22.50)      20 (21.98)      0.928

   Epilepsy                       31 (25.83)      21 (23.08)      0.645

  Causes of SE                                                    

   Acute stroke                   22 (18.33)      11 (12.09)      0.432

   AED withdrawal                 9 (7.50)        10 (10.99)      0.381

   Alcohol related                14 (11.67)      16 (17.58)      0.223

   Cardiac arrest                 11 (9.17)       7 (7.68)        0.704

   CNS infection                  7 (5.83)        12 (13.19)      0.065

   Septic encephalopathy          12 (10.00)      12 (13.19)      0.470

  Type of SE                                                      

   Generalized tonic--clonic      103 (95.37)     76 (93.83)      0.703

   Nonconvulsive                  1 (0.93)        2 (2.47)        0.703

   Epilepsia partialis continua   4 (3.70)        3 (3.70)        0.703

  Place of SE occurrence                                          

   Home                           106 (88.33)     55 (60.44)      \<0.001

   Primary Hospital               10 (8.33)       8 (8.79)        \<0.001

   Khon Kaen hospital             4 (3.33)        28 (30.77)      \<0.001

  History of previous SE          10 (8.33)       2 (2.20)        0.057
  ---------------------------------------------------------------------------

**Notes:** Poor outcome: discharge by death, not improved, or discharged against advice. Khon Kaen Hospital is a tertiary care hospital. Data presented as number (percentage) unless indicated.

**Abbreviations:** AED, antiepileptic drug; CNS, central nervous system; SD, standard deviation; SE, status epilepticus.

###### 

Physical signs and laboratory findings at initial presentation of patients with status epilepticus categorized by type of hospital discharge

  ----------------------------------------------------------------------------------------------
  Factors                                Good outcome\         Poor outcome\         *P*-value
                                         N=120                 N=91                  
  -------------------------------------- --------------------- --------------------- -----------
  Body temperature, °C                   37.22 (1.01)          37.42 (1.26)          0.219

  Systolic blood pressure, mmHg          138.22 (28.41)        138.24 (32.72)        0.996

  Pulse rate, bpm                        98.42 (23.40)         102.44 (24.75)        0.249

  Glasgow coma scale                     9.78 (3.51)           7.97 (4.01)           \<0.001

  Endotracheal intubation, n (%)         67 (58.26)            58 (65.17)            0.315

  Laboratory results                                                                 

   Hematocrit, %                         26.04 (17.53)         23.83 (17.76)         0.367

   White blood cell count, cells/mm^3^   8,492.60 (6,724.24)   8,411.43 (7,789.93)   0.936

   Plasma glucose, mg/dL                 159.26 (84.18)        203.11 (121.93)       0.006

   Blood urea nitrogen, mg/dL            13.32 (10.69)         31.09 (36.64)         \<0.001

   Creatinine, mg/dL                     1.18 (1.26)           2.01 (1.88)           \<0.001

   Serum sodium, mEq/L                   135.49 (8.03)         138.03 (6.57)         0.034

   Serum potassium, mEq/L                3.57 (0.89)           3.70 (0.77)           0.318

   Serum chloride, mEq/L                 99.27 (9.09)          103.30 (7.27)         0.006

   Serum bicarbonate, mEq/L              22.37 (4.81)          20.03 (5.82)          0.007

   Serum calcium, mg/dL                  8.44 (0.88)           8.30 (1.38)           0.532

   Serum phosphate, mg/dL                3.02 (1.12)           3.79 (2.27)           0.037

   Total cholesterol, mg/dL              168.08 (49.37)        158.87 (57.92)        0.555

   Serum albumin, g/dL                   3.52 (0.66)           2.73 (0.93)           \<0.001

   Serum ALT, U/L                        533.67 (61.28)        147.63 (275.02)       0.052

   Serum AST, U/L                        82.78 (102.35)        171.36 (205.69)       0.031

   Total bilirubin, mg/dL                1.04 (0.79)           1.84 (1.49)           0.017

   Alkaline phosphatase, mg/dL           111.31 (81.39)        106.89 (88.13)        0.857
  ----------------------------------------------------------------------------------------------

**Note:** Data presented as mean (standard deviation) unless indicated otherwise.

**Abbreviations:** ALT, alanine aminotransferase; AST, aspartate aminotransferase.

###### 

Treatment and treatment outcomes of patients with SE categorized by type of hospital discharge

  ------------------------------------------------------------------------------------------
  Factors                                    Good outcome\     Poor outcome\     *P*-value
                                             N=120             N=91              
  ------------------------------------------ ----------------- ----------------- -----------
  SE time prior to treatment, minutes        150.83 (257.64)   159.19 (344.43)   0.848

  SE treatment time to control SE, minutes   88.81 (175.08)    191.47 (621.38)   0.143

  Total SE time, minutes                     225.77 (268.90)   360.09 (723.49)   0.108

  Recurrent SE, n (%)                        13 (10.83)        39 (42.86)        \<0.001

  Interictal time, hours                     5.54 (12.24)      1.16 (6.59)       0.001

  Numbers of AED use                         2.55 (1.71)       2.44 (1.35)       0.612

  Types of AED use                                                               

  Primary AED                                                                    

   Diazepam, n (%)                           91 (75.83)        69 (75.82)        0.747

   Phenytoin, n (%)                          26 (21.67)        21 (23.08)        0.747

   Sodium valproate, n (%)                   3 (2.50)          1 (1.10)          0.747

  Secondary AED                                                                  

   Phenytoin, n (%)                          91 (98.91)        77 (100)          0.359

   Sodium valproate, n (%)                   1 (1.09)          0                 0.359

  Others                                                                         

   Midazolam, n (%)                          0                 3 (0.03)          0.079

   Propofol, n (%)                           0                 2 (0.02)          0.185

  Length of hospital stay, days              4.69 (6.12)       5.69 (7.50)       0.287

  Duration of respirator use, days           1.83 (3.92)       4.18 (6.21)       \<0.001

  Aspirated pneumonia, n (%)                 33 (27.50)        20 (21.98)        0.360
  ------------------------------------------------------------------------------------------

**Note:** Data presented as mean (standard deviation) unless indicated otherwise.

**Abbreviations:** AED, antiepileptic drug; SE, status epilepticus.
